Signaling mechanisms by which mitochondria regulates fibrosis in the lung
线粒体调节肺纤维化的信号机制
基本信息
- 批准号:9079520
- 负责人:
- 金额:$ 43.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos Flanking RegionAdenine NucleotidesAgeAgingAlveolarApoptosisApoptoticCell AgingCell DeathCell Membrane PermeabilityCellsCicatrixDiseaseElderlyElementsEpithelial CellsEtiologyEventExhibitsExtravasationFibrosisFunctional disorderGene ExpressionHamman-Rich syndromeHealthHomeostasisHumanInjuryInvestigationKnockout MiceLeadLinkLungLung diseasesMediator of activation proteinMessenger RNAMitochondriaMitochondrial DNAModelingMolecularMolecular ModelsMusMutationNatural regenerationNeurodegenerative DisordersPTEN-induced putative kinasePathogenesisPatternPermeabilityPhosphotransferasesPredispositionPrevalencePreventiveProtein IsoformsProteinsPulmonary FibrosisRegulationResearchRisk FactorsRoleSeminalSeveritiesSignal TransductionStagingStressSurfaceTelomeraseTestingTherapeutic EffectTranscription Repressor/CorepressorTransforming Growth Factor betaUp-Regulationactivating transcription factor 3age relatedbasecell agecis acting elementcytokineextracellularinjuredinsightmitochondrial dysfunctionmitochondrial membranemolecular modelingnew therapeutic targetnovelnovel therapeuticsoverexpressionpromoterpublic health relevanceresponsesurfactanttheoriestherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Despite the fact that Idiopathic Pulmonary Fibrosis (IPF) is a fatal and progressive lung disease of unknown etiology whose prevalence dramatically increases with age, few new pathobiologic models have emerged. Repetitive injury of mitochondrial-enriched type II alveolar epithelial cells (AECII) appears to be a key triggering event that leads to fibrosis, linked to secretion of pro- fibrotic cytokines, and increased apoptosis. Although AECII containing approximately 50% of the lung mitochondrial mass, the role of mitochondria in IPF pathobiology is unknown. We recently discovered that AECII from human IPF lung have accumulation of dysmorphic and dysfunctional mitochondria associated with very low expression of the crucial protective protein involved in mitochondrial homeostasis, PTEN-induced putative kinase 1 (PINK1) (J. Clin. Invest 2015). Low expression of PINK1 is associated with ER stress and aging, leading to increased susceptibility to cell apoptosis and fibrosis. However, no information is available how ER stress regulates PINK1 expression and how loss of PINK1 activates pro-fibrotic responses. Our novel preliminary studies suggest i) that the ER stress induces ATF3, a transcriptional repressor that reduced PINK1 levels leads to opening of the mitochondria permeability transition pore (mPTP) that sequentially leads to mitochondrial depolarization, apoptosis and leakage of mtDNA, a damage associated molecular pattern (DAMP) that induces TGF-β expression, and iii) PINK1 inhibits mPTP opening by interaction with the adenine nucleotide transporter 2/3 (ANT2/3), involved in mitochondrial pore opening negatively regulates PINK1 gene expression, ii) Based on these observations, we hypothesize that ER stress transcriptionally inhibits expression of the indispensable mitochondrial molecule, PINK1, in AECII thereby leading to mitochondrial dysfunction, via opening of the mPTP, apoptosis, and release of a mitochondrial DAMP that induces pro-fibrotic responses. To test this hypothesis, we propose: (1) To determine if ER stress induces ATF3 that transcriptionally silences PINK1 gene expression that promotes mitochondrial dysfunction in the AECII (Aim 1). Here, we will use AECII with specific deletion and overexpression of ATF3 to analyze its contribution to PINK1 mRNA synthesis and its ability to impair mitochondrial homeostasis, and ATF3 knockout mice to study their susceptibility to lung fibrosis. In addition, we will interrogate the PINK1 promoter to determine core cis-acting elements regulated by ATF3. (2) To investigate if PINK1 deficiency alters the mitochondrial membrane permeability that drives apoptosis and promotion of pro-fibrotic responses. We hypothesize that PINK1 through a novel interaction represses ANT2/3, the latter promotes mitochondrial membrane permeability in AECII. We will evaluate how PINK1-ANT2/3 interaction is essential in limiting the opening of the mPTP, reducing apoptosis, restricting release of mitochondrial DAMPs, and inducing TGF-β expression. In addition, we will analyze whether a neo-substrate for PINK1 that amplifies its catalytic activity will have a preventive and/or therapeutic effect against PINK1 deficiency-associated mitochondria damage and lung fibrosis. Overall, these studies bring forth a unique molecular model linking PINK1-deficiency to mitochondrial dysfunction, ensuing extracellular release of DAMPs, and the profibrotic response that sets the stage for identifying novel therapeutic targets in ameliorating severity of fibrosis in IPF.
描述(由申请方提供):尽管特发性肺纤维化(IPF)是一种病因不明的致死性和进行性肺部疾病,其患病率随着年龄的增长而显著增加,但几乎没有新的病理生物学模型出现。肺泡富含II型肺泡上皮细胞(AECII)的重复损伤似乎是导致纤维化的关键触发事件,其与促纤维化细胞因子的分泌和增加的细胞凋亡有关。尽管AECII含有约50%的肺线粒体质量,但线粒体在IPF病理生物学中的作用尚不清楚。我们最近发现,来自人IPF肺的AECII具有与参与线粒体稳态的关键保护蛋白PTEN诱导的推定激酶1(PINK 1)的极低表达相关的畸形和功能障碍线粒体的积累(J. Clin. Invest 2015)。PINK 1的低表达与ER应激和衰老相关,导致对细胞凋亡和纤维化的易感性增加。然而,没有关于ER应激如何调节PINK 1表达以及PINK 1缺失如何激活促纤维化反应的信息。我们的新的初步研究表明i)ER应激诱导ATF 3,一种转录抑制因子,其降低PINK 1水平导致线粒体通透性转换孔(mPTP)打开,从而导致线粒体去极化、凋亡和mtDNA泄漏,这是一种诱导TGF-β表达的损伤相关分子模式(DAMP),和iii)PINK 1通过与腺嘌呤核苷酸转运蛋白2/3(ANT 2/3)相互作用抑制mPTP开放,参与线粒体孔开放负调节PINK 1基因表达,ii)基于这些观察,我们假设ER应激在转录上抑制AECII中不可缺少的线粒体分子PINK 1的表达,从而通过mPTP的开放、细胞凋亡和诱导促纤维化反应的线粒体DAMP的释放导致线粒体功能障碍。为了验证这一假设,我们提出:(1)确定ER应激是否诱导转录沉默PINK 1基因表达的ATF 3,从而促进AECII中的线粒体功能障碍(目的1)。在这里,我们将使用AECII与特定的缺失和过表达的ATF 3来分析其对PINK 1 mRNA合成的贡献及其损害线粒体稳态的能力,和ATF 3敲除小鼠来研究它们对肺纤维化的易感性。此外,我们将询问PINK 1启动子,以确定由ATF 3调控的核心顺式作用元件。(2)研究PINK 1缺陷是否改变了线粒体膜通透性,从而驱动细胞凋亡和促进促纤维化反应。我们推测PINK 1通过一种新的相互作用抑制了ANT 2/3,后者促进了AECII中线粒体膜的通透性。我们将评估PINK 1-ANT 2/3相互作用如何在限制mPTP开放、减少凋亡、限制线粒体DAMP释放和诱导TGF-β表达中发挥重要作用。此外,我们将分析PINK 1的新底物是否会放大其催化活性,对PINK 1缺陷相关的线粒体损伤和肺纤维化具有预防和/或治疗作用。总的来说,这些研究提出了一个独特的分子模型,将PINK 1缺陷与线粒体功能障碍联系起来,从而导致DAMP的细胞外释放,以及促纤维化反应,为确定改善IPF纤维化严重程度的新治疗靶点奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ana Lucia Mora其他文献
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity.
化学合成疟疾疫苗 SPf66 的首次现场试验:安全性、免疫原性和保护性。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:5.5
- 作者:
R. Amador;Alberto Moreno;V. Valero;Luis Angel Murillo;Ana Lucia Mora;M. Rojas;Claudia L. Rocha;Margarita Salcedo;Fanny Guzmán;Fabiola Espejo;Francisco Nũnez;Manuel E. Patarroyo - 通讯作者:
Manuel E. Patarroyo
Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia
在哥伦比亚接种 SPf66(一种化学合成疫苗)来预防恶性疟原虫疟疾
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:0
- 作者:
M. V. Valero;L. R. Amador;C. Galindo;J. Figueroa;M. Belló;Luis Angel Murillo;Ana Lucia Mora;G. Patarroyo;Claudia L. Rocha;Mauricio Rojas;J. J. Aponte;L. E. Sarmiento;D. Lozada;C. Coronell;N. M. Ortega;Jaiver E. Rosas;M. E. Patarroyo;P. Alonso - 通讯作者:
P. Alonso
ER-Stress Drives the Increased Susceptibility To Lung Fibrosis in Aging Individuals Through a ROS-Mediated Mechanism
- DOI:
10.1016/j.freeradbiomed.2011.10.421 - 发表时间:
2011-11-01 - 期刊:
- 影响因子:
- 作者:
Marta Bueno;Patrick Joseph Pagano;Mauricio Rojas;Ana Lucia Mora - 通讯作者:
Ana Lucia Mora
Ana Lucia Mora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ana Lucia Mora', 18)}}的其他基金
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10392756 - 财政年份:2020
- 资助金额:
$ 43.48万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10539344 - 财政年份:2020
- 资助金额:
$ 43.48万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10307623 - 财政年份:2020
- 资助金额:
$ 43.48万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10063554 - 财政年份:2019
- 资助金额:
$ 43.48万 - 项目类别:
Signaling mechanisms by which mitochondria regulates fibrosis in the lung
线粒体调节肺纤维化的信号机制
- 批准号:
9233787 - 财政年份:2016
- 资助金额:
$ 43.48万 - 项目类别:
Aging and Lung Disease: Clinical Impact and Cellular and Molecular Pathways
衰老与肺部疾病:临床影响以及细胞和分子途径
- 批准号:
8785180 - 财政年份:2014
- 资助金额:
$ 43.48万 - 项目类别:
相似海外基金
Influence of the polymorphism of 5'-flanking region of SAA1 gene on SAA1 transcriptional activity
SAA1基因5侧翼区多态性对SAA1转录活性的影响
- 批准号:
13670479 - 财政年份:2001
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of The 5'-Flanking Region of the Stress Response Gene, Osp94
应激反应基因 Osp94 5-侧翼区域的表征
- 批准号:
12672132 - 财政年份:2000
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mdecular cloning and analysis of S' -flanking region of human MYPT1 gene
人MYPT1基因S侧翼区的分子克隆与分析
- 批准号:
10670645 - 财政年份:1998
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANALYSIS OF CYCLIN D1 GENE EXPRESSION BY METHYLATION OF CpG ISLAND LOCATED 5'-FLANKING REGION
5-侧翼区 CpG 岛甲基化分析细胞周期蛋白 D1 基因表达
- 批准号:
09670226 - 财政年份:1997
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANALYSIS OF TWO PROMOTERS AND 5'FLANKING REGION OF RAT SERINE : PYRUVATE AMINOTRANSFERASE GENE
大鼠丝氨酸丙酮酸转氨酶基因的两个启动子和5侧翼区的分析
- 批准号:
05680546 - 财政年份:1993
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Characterization of 5 prime flanking region of 230 kDa bullous pemphigoid antigen gene
230 kDa 大疱性类天疱疮抗原基因 5 主要侧翼区域的表征
- 批准号:
05670718 - 财政年份:1993
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Syndrome of extreme insulin resistance due to decreased promoter activity of 5'-flanking region of insulin receptor gene.
由于胰岛素受体基因 5-侧翼区域启动子活性降低而导致的极端胰岛素抵抗综合征。
- 批准号:
03454513 - 财政年份:1991
- 资助金额:
$ 43.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)